Topic: ECTRIMS 2015
New data on first-line oral therapies in MS
November 4, 2015Late-breaking news at ECTRIMS 2015: ocrelizumab, minocycline and biotin
October 28, 2015Long-term outcomes of HSCT in MS
October 10, 2015Need for early, effective treatment: MSBase investigators
October 10, 2015OPERA I/OPERA II results for ocrelizumab in RRMS
October 10, 2015Is MS ever benign?
October 9, 2015Novel therapies in development: 4 reports
October 9, 2015Predictive value of NEDA and brain atrophy in MS
October 9, 2015Too few patients considered candidates for treatment optimization
October 8, 20151